UBD and cancer: Among UPS components, ubiquitin-like modifiers (UBLs) have emerged as critical regulators of substrate specificity, with Ubiquitin D (UBD/FAT10) representing a unique cytokine-inducible UBL that bridges inflammation, immunity, and cancer (2, 3).